Terms ending in 2033
Every in-force patent on Pharmacyclics, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,133,134 | Inhibitors of Bruton's Tyrosine Kinase In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 9,713,617 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 9,725,455 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 9,828,383 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 10,065,968 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 10,106,548 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 10,125,140 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · High confidence | Pharmacyclics LLC | In force | High confidence | |
| US 10,266,540 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 10,294,231 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| US 10,294,232 | Crystalline Forms of a Bruton's Tyrosine Kinase Inhibitor In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | |
| 8 more term ends in 2033 · Pro | |||||
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
17 of these are in force and held by Pharmacyclics, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.